Clinical trials
Leukemia trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 3 |
| 2009 | 3 |
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 10 |
| Active, not recruiting | 2 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Princess Maxima Center for Pediatric Oncology | 4 |
| Rigshospitalet, Denmark | 4 |
| Novartis Pharmaceuticals | 3 |
| Mats Heyman | 2 |
| Pfizer | 2 |
| Aarhus University Hospital | 1 |
| Acerta Pharma BV | 1 |
| Celgene | 1 |
| Copenhagen University Hospital at Herlev | 1 |
| European Working Group of MDS in Childhood | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 27 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 9 |
| Leukemia, Myeloid | 5 |
| Neoplasms | 5 |
| Hematologic Diseases | 4 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 |
| Bone Marrow Diseases | 3 |
| Hematologic Neoplasms | 3 |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 |
Trials
Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.